Bloomberg News

Rite Aid Surges After 2015 Sales Forecast Tops Analyst Estimates

April 10, 2014

Rite Aid (RAD:US) Corp. rose to its highest value in a dozen years after the third-largest U.S. drugstore company provided a full-year sales forecast higher than analysts’ estimates.

Rite Aid gained 11 percent to $7.12 at 11:14 a.m. New York time after increasing to $7.39, its highest intraday price since Oct. 2, 2001. The shares of the Camp Hill, Pennsylvania-based company more than tripled in the 12 months through yesterday.

Revenue for fiscal 2015 is expected to be $26 billion to $26.5 billion, Rite Aid said in a statement today. That was more than analysts’ average estimate of $25.8 billion. Sales for the fourth quarter ended Feb. 28 were $6.6 billion, also higher than estimates.

Rite Aid is now positioned “to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail health-care company,” Chief Executive Officer John Standley said in the statement.

To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net

To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Bruce Rule, Robert Valpuesta


Silicon Valley State of Mind
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • RAD
    (Rite Aid Corp)
    • $6.43 USD
    • -0.03
    • -0.47%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus